//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
A new UK drug approval pathway speeds up access to medicines, but who really benefits? New editorial by LSE Health's Huseyin Naci in @bmj.com argues it prioritises industry over patients and the NHS. 💊 READ NOW: doi.org/10.1136/bmj.... #HealthPolicy #NHS #NICE
7d
LSE Health Policy